Alkem Laboratories Ltd.
Fundamentals
- Market cap
- ₹64,864 cr
- P/E
- 28.18×
- ROE
- 18.07%
- Debt / equity
- 0.09
- Div yield
- 0.98%
- 52-week range
- 4716.20 — 5933.50
Company snapshot
Alkem Laboratories Ltd.
Pharmaceuticals
₹64,765 cr
P/E 28.14×
Latest quarter · Mar 2026
Sales₹3,603 cr
Net profit₹252 cr
Op. margin+14.4%
EPS₹19.78
Strength & growth
Debt / equity0.09×
Current ratio2.73×
Sales CAGR+11.3%
EPS CAGR+11.1%
The timeline — 3 notes on Alkem Laboratories Ltd.
June 2026
- 03 Jun 26 · 5:39 PM IST Brief Brief · Large cap
Alkem promoter trust sells ₹288 cr stake, says cash goes to beneficiaries
A 0.46% open-market sale by the Samprada and Nanhamati Singh Family Trust on June 2 trimmed its holding to 18.28%. The trust says it's for an internal payout.
- 02 Jun 26 · 3:18 PM IST Brief Brief · Large cap
Alkem undercuts pen injectors with India's first ₹350 semaglutide syringe
A single-shot format at a low price point is designed to widen access to a drug currently dominated by pricier delivery devices.